LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Microfluidic Device Rapidly Detects Urinary Tract Infections

By LabMedica International staff writers
Posted on 23 Aug 2015
Print article
Image: The workflow of the Lab-on-a-Disc device for identifying bacteria in urine samples. From left to right (i) Urine sample from patient; (ii) Capturing bacteria in V-cup-structures on a Lab-on-a-Disk platform by centrifugation; (iii) Raman spectroscopic analysis of captured bacteria within the V-cups; (iv) Fingerprint-like spectroscopic information on the UTI pathogen (Photo courtesy of Ute Neugebauer).
Image: The workflow of the Lab-on-a-Disc device for identifying bacteria in urine samples. From left to right (i) Urine sample from patient; (ii) Capturing bacteria in V-cup-structures on a Lab-on-a-Disk platform by centrifugation; (iii) Raman spectroscopic analysis of captured bacteria within the V-cups; (iv) Fingerprint-like spectroscopic information on the UTI pathogen (Photo courtesy of Ute Neugebauer).
Image: The alpha300 R Superior Confocal Raman Imaging System (Photo courtesy of WITec).
Image: The alpha300 R Superior Confocal Raman Imaging System (Photo courtesy of WITec).
A polymeric centrifugal microfluidic platform has been developed for the rapid and sensitive identification of bacteria directly from urine, thus eliminating time-consuming cultivation steps.

Untreated urinary tract infections can quickly move to a life-threatening condition and cases may trigger sepsis, which occurs when the immune system, in an attempt to fight off the infection, inadvertently activates body-wide inflammation that can cause blood clots and leaky blood vessels.

Scientists at the Jena University Hospital (Germany) have created a Lab-on-a-Disc platform that combines microfluidics and Raman microscopy, a modern optical detection method. The platform utilizes the rotationally induced centrifugal field to efficiently capture bacteria directly from suspension within a glass-polymer hybrid chip. Once trapped in an array of small V-shaped structures, the bacteria are readily available for spectroscopic characterization, such as Raman spectroscopic fingerprinting, providing valuable information on the characteristics of the captured bacteria.

Anonymized urine samples were provided by the hospital’s Institute of Medical Microbiology. They originated from different patients with single pathogen urinary tract infections (UTIs) of Enterococcus faecalis and Escherichia coli. To remove bigger particles such as leukocytes or epithelial cells, the urine samples were run through membrane filters, centrifuged, the pellet washed twice with phosphate buffered saline (PBS), and is finally re-suspended in PBS before being loaded into the device. A CRM 300 micro-Raman setup (WITec, Ulm, Germany), equipped with a 600 lines/mm grating was used for micro-Raman measurements.

The whole procedure, including sample preparation, requires about one hour to obtain a valuable result, marking a significant reduction in diagnosis time when compared to the 24 hours and more, typically required for standard microbiological methods. Characterization of the captured bacteria by label-free conventional micro-Raman spectroscopy allows rapid identification of the pathogens with their characteristic features, which is valuable for first screening analysis. The device has been easily adapted for fluorescence measurements, paving the way for the development of microfluidics-based immunochemical assays, illustrating a high potential of the device for numerous applications in spectroscopy-based point-of-care diagnostics.

Ulrich-Christian Schröder, a doctoral student and lead author of the study said, “Our device works by loading a few microliters of a patient's urine sample into a tiny chip, which is then rotated with a high angular velocity so that any bacteria is guided by centrifugal force through microfluidic channels to a small chamber where 'V-cup capture units' collect it for optical investigation. We were able to identify Escherichia coli and Enterococcus faecalis within 70 minutes, directly from patients' urine samples.” The study was published on August 11, 2015, in the journal Biomicrofluidics.

Related Links:

Jena University Hospital
WITec 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more